These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26487104)

  • 1. Patent foramen ovale: the current state of play.
    Asrress KN; Marciniak M; Marciniak A; Rajani R; Clapp B
    Heart; 2015 Dec; 101(23):1916-25. PubMed ID: 26487104
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent foramen ovale.
    Dattilo PB; Kim MS; Carroll JD
    Cardiol Clin; 2013 Aug; 31(3):401-15. PubMed ID: 23931102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic evaluation of patent foramen ovale prior to device closure.
    Rana BS; Thomas MR; Calvert PA; Monaghan MJ; Hildick-Smith D
    JACC Cardiovasc Imaging; 2010 Jul; 3(7):749-60. PubMed ID: 20633854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale and cryptogenic stroke: many unanswered questions.
    Roth C; Alli O
    Cleve Clin J Med; 2014 Jul; 81(7):417-24. PubMed ID: 24987042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials.
    Carroll AM; Carroll JD
    Curr Cardiol Rep; 2019 Apr; 21(6):48. PubMed ID: 31011896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of patent foramen ovale for hypoxemia during left ventricular assist device support.
    Loforte A; Violini R; Musumeci F
    J Card Surg; 2012 Jul; 27(4):528-9. PubMed ID: 22607124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis After Percutaneous Foramen Ovale Closure Among Patients With Platypnea-Orthodeoxia Syndrome.
    Hayek A; Rioufol G; Bochaton T; Rossi R; Mewton N; Paccalet A; Bonnefoy-Cudraz E; Thibault H; Derimay F
    J Am Coll Cardiol; 2021 Nov; 78(18):1844-1846. PubMed ID: 34711343
    [No Abstract]   [Full Text] [Related]  

  • 9. Patent foramen ovale.
    Silva GV
    Tex Heart Inst J; 2014 Jun; 41(3):306-8. PubMed ID: 24955048
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent foramen ovale.
    Homma S; Messé SR; Rundek T; Sun YP; Franke J; Davidson K; Sievert H; Sacco RL; Di Tullio MR
    Nat Rev Dis Primers; 2016 Jan; 2():15086. PubMed ID: 27188965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Quantification of Patent Foramen Ovale-Mediated Shunts: Echocardiography and Transcranial Doppler.
    Mahmoud AN; Elgendy IY; Agarwal N; Tobis JM; Mojadidi MK
    Interv Cardiol Clin; 2017 Oct; 6(4):495-504. PubMed ID: 28886841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale closure for secondary stroke prevention.
    Alkhouli M; Sievert H; Holmes DR
    Eur Heart J; 2019 Jul; 40(28):2339-2350. PubMed ID: 30957864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestation and current management of patent foramen ovale.
    Cruz-González I; Solis J; Kiernan TJ; Yan BP; Lam YY; Palacios IF
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):1011-22. PubMed ID: 19673678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
    Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
    J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Images and case reports in interventional cardiology. Left atrial hypertension as a result of occlusion of a patent foreman ovale.
    Kim E; Slater JN; Kronzon I
    Circ Cardiovasc Interv; 2010 Jun; 3(3):e4-5. PubMed ID: 20551389
    [No Abstract]   [Full Text] [Related]  

  • 18. A rocking motion of a patent foramen ovale device.
    Savaş G; Yazici S; Dinc Asarcikli L; Terzi S
    Anatol J Cardiol; 2020 Oct; 24(4):E12-E13. PubMed ID: 33001048
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale, systemic embolization, and closure.
    Holmes DR; Cohen HA; Ruiz C
    Curr Probl Cardiol; 2009 Oct; 34(10):483-530. PubMed ID: 19733784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.